EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A guide to the ecological limitations of phage therapy of bacterial biofilms: Is what's best for the phage best for the physician?

Stephen T Abedon iD

The FEBS Journal · 2026-11 · 293 (21) · 6293-6307

DOI: 10.1111/febs.70615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 08.06.2026. Verfasst von Stephen T Abedon. Beteiligte Einrichtung: Department of Microbiology, The Ohio State University, Mansfield, OH, USA. Hauptthemen laut MEDLINE: Biofilms, Phage Therapy, Bacteriophages, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, U.S. Public Health Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial biofilms—structured communities of bacteria encased in self‐produced polymeric matrices—present formidable challenges in clinical medicine. The resistance of biofilms to conventional antibiotics stems from multiple factors. These include limited drug penetration and the presence of metabolically dormant bacteria that survive treatments, despite their retaining sensitivity under standard laboratory conditions. Bacteriophages (phages), the viruses that infect and kill bacteria, have emerged as promising alternatives or adjuncts to antibiotic therapy, including against bacterial biofilms. Phages, nonetheless, likely evolved to optimize especially their dissemination between spatially separated bacteria, including spatially separated biofilms, rather than to become specialists at eradicating all targeted bacteria from biofilms. By contrast, complete bacterial elimination from the body is the standard goal of antibacterial therapies. Considered here is how an understanding of these competing goals—virion dissemination vs. complete bacterial eradication—can inform our development of phage‐based anti‐biofilm therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsPhage TherapyBacteriophagesBacteriaBacterial InfectionsHumansAnti-Bacterial Agents

Stichwörter der Autor:innen

antimicrobial resistancebacteriophage therapybiofilmburst sizeextracellular polymeric substancelatent period

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, The Ohio State University, Mansfield, OH, USA.

ORCID-Profile: Stephen T Abedon

Förderung

  • NIAID NIH HHS
  • U.S. Public Health Service

Zitieren

APA

Abedon, S. T. (2026). A guide to the ecological limitations of phage therapy of bacterial biofilms: Is what's best for the phage best for the physician?. The FEBS Journal, 293(21), 6293-6307. https://doi.org/10.1111/febs.70615

Vancouver

Abedon ST. A guide to the ecological limitations of phage therapy of bacterial biofilms: Is what's best for the phage best for the physician?. The FEBS Journal. 2026;293(21):6293-6307. doi:10.1111/febs.70615

BibTeX
@article{Abedon2026,
  author = {Abedon, Stephen T},
  title = {A guide to the ecological limitations of phage therapy of bacterial biofilms: Is what's best for the phage best for the physician?},
  journal = {The FEBS Journal},
  year = {2026},
  volume = {293},
  number = {21},
  pages = {6293--6307},
  doi = {10.1111/febs.70615}
}
Kostenlos starten →